Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TENKU

TenX Keane Acquisition (TENKU)

TenX Keane Acquisition
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TENKU
DateTimeSourceHeadlineSymbolCompany
22/05/202405:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
21/05/202407:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
16/05/202406:24Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TENKUTenX Keane Acquisition
31/01/202409:25Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:TENKUTenX Keane Acquisition
19/01/202408:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
11/01/202408:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
11/01/202407:21Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TENKUTenX Keane Acquisition
11/01/202406:29GlobeNewswire Inc.TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment ProposalNASDAQ:TENKUTenX Keane Acquisition
09/01/202408:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TENKUTenX Keane Acquisition
29/12/202304:39Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TENKUTenX Keane Acquisition
21/11/202309:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
24/10/202322:42Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:TENKUTenX Keane Acquisition
24/10/202322:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
24/10/202322:30PR Newswire (US)Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.NASDAQ:TENKUTenX Keane Acquisition
24/10/202322:30GlobeNewswire Inc.Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.NASDAQ:TENKUTenX Keane Acquisition
19/10/202308:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
19/10/202307:00GlobeNewswire Inc.TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationNASDAQ:TENKUTenX Keane Acquisition
17/08/202304:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
19/07/202306:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
19/07/202306:00GlobeNewswire Inc.TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationNASDAQ:TENKUTenX Keane Acquisition
16/05/202306:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TENKUTenX Keane Acquisition
01/04/202307:33Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TENKUTenX Keane Acquisition
15/02/202307:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
11/02/202308:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TENKUTenX Keane Acquisition
09/02/202300:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
08/02/202322:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
07/12/202209:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TENKUTenX Keane Acquisition
07/12/202208:58GlobeNewswire Inc.TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022NASDAQ:TENKUTenX Keane Acquisition
25/10/202208:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TENKUTenX Keane Acquisition
19/10/202205:20GlobeNewswire Inc.TenX Keane Acquisition Announces Closing of $66 Million Initial Public Offering, Including Partial Exercise of Underwriter’s Over-Allotment OptionNASDAQ:TENKUTenX Keane Acquisition
 Showing the most relevant articles for your search:NASDAQ:TENKU